[Investigate of the etiology and prevention status of liver cirrhosis].

医学 肝硬化 病因学 胃肠病学 内科学 脂肪肝 入射(几何) 酒精性肝病 慢性肝病 肝病 非酒精性脂肪肝 肝炎 疾病 物理 光学
作者
Er Hei DAI,Xiaoming Guo,Junhui Wang,Qikun Hu,Jiang‐Tao Li,Qinhao Tang,Haoran Zu,Hao Huan,Y Wang,Yufeng Gao,Gaobin Hu,Wen-Cheng Li,Z J Liu,Q P,Youliang Song,Jianghua Yang,Ying Zhu,S D Huang,Zhongji Meng,Binqiang Bai
出处
期刊:PubMed [National Institutes of Health]
卷期号:103 (12): 913-919 被引量:4
标识
DOI:10.3760/cma.j.cn112137-20221017-02164
摘要

Objective: To investigate the etiology, prevention and treatment status, and their corresponding regional differences of the patients with liver cirrhosis in China, in order to provide scientific basis for the development of diagnosis and control strategies in China. Methods: Clinical data of patients diagnosed with liver cirrhosis for the first time through January 1, 2018 to December 31, 2020 from 50 hospitals in seven different regions of China were collected and analyzed retrospectively, and the difference of etiology, treatment, and their differences in various regions were analyzed. Results: A total of 11 861 cases with liver cirrhosis were included in the study. Thereinto, 5 093 cases (42.94%) were diagnosed as compensated cirrhosis, and 6 768 cases (57.06%) had decompensated cirrhosis. Notably, 8 439 cases (71.15%) were determined as chronic hepatitis B-caused cirrhosis, 1 337 cases (11.27%) were alcoholic liver disease, 963 cases (8.12%) were chronic hepatitis C, 698 cases (5.88%) were autoimmune liver disease, 367 cases (3.09%) were schistosomiasis, 177 cases (1.49%) were nonalcoholic fatty liver, and 743 cases (6.26%) of other types of liver disease. There were significant differences in the incidence of chronic hepatitis B, chronic hepatitis C, alcoholic liver disease, fatty liver, schistosomiasis liver disease, and autoimmune liver disease among the seven regions (P<0.001). Only 1 139 cases (9.60%) underwent endoscopic therapy, thereinto, 718 cases (6.05%) underwent surgical therapy, and 456 cases (3.84%) underwent interventional therapy treatment. In patients with compensated liver cirrhosis, 60 cases (0.51%) underwent non-selective β receptor blockers(NSBB), including 59 cases (0.50%) underwent propranolol and 1 case (0.01%) underwent carvedilol treatment. In patients with decompensated liver cirrhosis, 310 cases (2.61%) underwent NSBB treatment, including 303 cases (2.55%) underwent propranolol treatment and 7 cases (0.06%) underwent carvedilol treatment. Interestingly, there were significant differences in receiving endoscopic therapy, interventional therapy, NSBB therapy, splenectomy and other surgical treatments among the seven regions (P<0.001). Conclusion: Currently, chronic hepatitis B is the main cause (71.15%) of liver cirrhosis in several regions of China, and alcoholic liver disease has become the second cause (11.27%) of liver cirrhosis in China. The three-level prevention and control of cirrhosis in China should be further strengthened.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Jasper的应助被平常的芝麻采纳,获得10
刚刚
2秒前
3秒前
wyq发布了新的文献求助10
4秒前
4秒前
4秒前
糟糕的以南完成签到,获得积分10
4秒前
科研通AI6.3的应助被钱罐罐采纳,获得10
6秒前
我欣永恒发布了新的文献求助10
6秒前
开放剑鬼完成签到,获得积分10
6秒前
Owen的应助被发文章12138采纳,获得10
7秒前
dxftx发布了新的文献求助10
7秒前
7秒前
李健的应助被少喵几句采纳,获得30
8秒前
丘比特的应助被专注映安采纳,获得10
9秒前
9秒前
9秒前
nana完成签到,获得积分10
9秒前
11秒前
Pdnnnnn发布了新的文献求助10
11秒前
11秒前
MchemG的应助被12采纳,获得30
12秒前
我是老大的应助被田园采纳,获得10
12秒前
CodeCraft的应助被hbuiio采纳,获得10
12秒前
罗小黑完成签到 ,获得积分10
12秒前
kalani发布了新的文献求助10
12秒前
李健的粉丝团团长的应助被zimi采纳,获得10
13秒前
Jasper的应助被荀汐采纳,获得10
13秒前
14秒前
14秒前
14秒前
15秒前
melo完成签到,获得积分10
16秒前
16秒前
我要读博士完成签到,获得积分10
17秒前
LJH发布了新的文献求助10
17秒前
17秒前
18秒前
李小能完成签到 ,获得积分10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189431
求助须知:如何正确求助?哪些是违规求助? 9576755
关于积分的说明 21849578
捐赠科研通 7787361
什么是DOI,文献DOI怎么找? 3435577
关于科研通互助平台的介绍 2559772
邀请新用户注册赠送积分活动 2482529